GL1X · GenesisL1 explorer

Research workbench

Catalytic domain of human parp-1 in complex with the inhibitor MC2050

Analyse Catalytic domain of human parp-1 in complex with the inhibitor MC2050 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6XVW
Type
protein
Length
691 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Poly [ADP-ribose] polymerase 1
EC
2.4.2.30, 2.4.2.-
UniProt
P09874
Ligands
O3H, NI
Pockets
9 · best druggability 0.82

Structure

x-ray diffraction · 2 distinct chains · 40% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APoly [ADP-ribose] polymerase 1 (EC 2.4.2.30, 2.4.2.-)protein34539% helix, 25% strandP09874
BPoly [ADP-ribose] polymerase 1 (EC 2.4.2.30, 2.4.2.-)protein34640% helix, 25% strandP09874

Ligands and binding sites

  • O3H · 2-[2-(4-pyridin-2-ylpiperazin-1-yl)ethylsulfanyl]-3~{H}-quinazolin-4-one · ligand · 2 copies · chains A, B
  • NI · Nickel (II) ion · metal · 6 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 8 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16330.820.8764O3H
26120.820.8756NI, O3H
35240.700.8051NI
41150.480.7920empty
51480.480.7723empty

Interfaces

1 interface between chains.

  • A–B · 1234 Ų buried · 13 hydrogen bonds · protein-protein

Compared structures

  • 6XVW · Catalytic domain of human PARP-1 in complex with the inhibitor MC2050 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.